Issue 3/2016
Content (29 Articles)
Radiopharmaceuticals in paraganglioma imaging: too many members on board?
David Taïeb, Rodney J. Hicks, Karel Pacak
68Ga-PSMA-HBED-CC PET/CT: where molecular imaging has an edge over morphological imaging
Felix M. Mottaghy, Florian F. Behrendt, Frederik A. Verburg
Extent of disease in recurrent prostate cancer determined by [68Ga]PSMA-HBED-CC PET/CT in relation to PSA levels, PSA doubling time and Gleason score
Frederik A. Verburg, David Pfister, Axel Heidenreich, Andreas Vogg, Natascha I. Drude, Stefan Vöö, Felix M. Mottaghy, Florian F. Behrendt
Predictive value of 18F-FDG PET/CT in restaging patients affected by ovarian carcinoma: a multicentre study
Federico Caobelli, Pierpaolo Alongi, Laura Evangelista, Maria Picchio, Giorgio Saladini, Marco Rensi, Onelio Geatti, Angelo Castello, Iashar Laghai, Cristina E. Popescu, Carlotta Dolci, Cinzia Crivellaro, Silvia Seghezzi, Margarita Kirienko, Vincenzo De Biasi, Fabrizio Cocciolillo, Natale Quartuccio
Image interpretation criteria for FDG PET/CT in multiple myeloma: a new proposal from an Italian expert panel. IMPeTUs (Italian Myeloma criteria for PET USe)
Cristina Nanni, Elena Zamagni, Annibale Versari, Stephane Chauvie, Andrea Bianchi, Marco Rensi, Marilena Bellò, Ilaria Rambaldi, Andrea Gallamini, Francesca Patriarca, Francesca Gay, Barbara Gamberi, Michele Cavo, Stefano Fanti
Prediction of neoadjuvant radiation chemotherapy response and survival using pretreatment [18F]FDG PET/CT scans in locally advanced rectal cancer
Ji-In Bang, Seunggyun Ha, Sung-Bum Kang, Keun-Wook Lee, Hye-Seung Lee, Jae-Sung Kim, Heung-Kwon Oh, Ho-Young Lee, Sang Eun Kim
Molecular response assessed by 68Ga-DOTANOC and survival after 90Y microsphere therapy in patients with liver metastases from neuroendocrine tumours
Luca Filippi, Francesco Scopinaro, Giuseppe Pelle, Roberto Cianni, Rita Salvatori, Orazio Schillaci, Oreste Bagni
Long-term results of PRRT in advanced bronchopulmonary carcinoid
Annapaola Mariniello, Lisa Bodei, Carmine Tinelli, Silvia Melania Baio, Laura Gilardi, Marzia Colandrea, Stefano Papi, Giuseppe Valmadre, Nicola Fazio, Domenico Galetta, Giovanni Paganelli, Chiara Maria Grana
Subacute haematotoxicity after PRRT with 177Lu-DOTA-octreotate: prognostic factors, incidence and course
Hendrik Bergsma, Mark W. Konijnenberg, Boen L. R. Kam, Jaap J. M. Teunissen, Peter P. Kooij, Wouter W. de Herder, Gaston J. H. Franssen, Casper H. J. van Eijck, Eric P. Krenning, Dik J. Kwekkeboom
Recurrent renal cell carcinoma: clinical and prognostic value of FDG PET/CT
Pierpaolo Alongi, Maria Picchio, Fabio Zattoni, Marianna Spallino, Luigi Gianolli, Giorgio Saladini, Laura Evangelista
Vesicular monoamine transporter protein expression correlates with clinical features, tumor biology, and MIBG avidity in neuroblastoma: a report from the Children’s Oncology Group
William Temple, Lori Mendelsohn, Grace E. Kim, Erin Nekritz, W. Clay Gustafson, Lawrence Lin, Kathy Giacomini, Arlene Naranjo, Collin Van Ryn, Gregory A. Yanik, Susan G. Kreissman, Michael Hogarty, Katherine K. Matthay, Steven G. DuBois
Influence of 18F-FDG PET/CT on therapy management in patients with stage III/IV malignant melanoma
Susann-Cathrin Schüle, Thomas Kurt Eigentler, Claus Garbe, Christian la Fougère, Konstantin Nikolaou, Christina Pfannenberg
High treatment efficacy by dual targeting of Burkitt’s lymphoma xenografted mice with a 177Lu-based CD22-specific radioimmunoconjugate and rituximab
Tobias Weber, Benedikt Bötticher, Walter Mier, Max Sauter, Susanne Krämer, Karin Leotta, Armin Keller, Anne Schlegelmilch, Ludger Grosse-Hovest, Dirk Jäger, Uwe Haberkorn, Michaela A. E. Arndt, Jürgen Krauss
Cross-validation of biomarkers for the early differential diagnosis and prognosis of dementia in a clinical setting
Daniela Perani, Chiara Cerami, Silvia Paola Caminiti, Roberto Santangelo, Elisabetta Coppi, Laura Ferrari, Patrizia Pinto, Gabriella Passerini, Andrea Falini, Sandro Iannaccone, Stefano Francesco Cappa, Giancarlo Comi, Luigi Gianolli, Giuseppe Magnani
Distinct spatiotemporal patterns for disease duration and stage in Parkinson’s disease
Simon Badoud, Nicolas Nicastro, Valentina Garibotto, Pierre R. Burkhard, Sven Haller
Different loss of dopamine transporter according to subtype of multiple system atrophy
Hae Won Kim, Jae Seung Kim, Minyoung Oh, Jungsu S. Oh, Sang Joo Lee, Seung Jun Oh, Sun Ju Chung, Chong Sik Lee
Does posterior cingulate hypometabolism result from disconnection or local pathology across preclinical and clinical stages of Alzheimer’s disease?
Stefan Teipel, Michel J. Grothe
PET imaging evaluation of [18F]DBT-10, a novel radioligand specific to α7 nicotinic acetylcholine receptors, in nonhuman primates
Ansel T. Hillmer, Ming-Qiang Zheng, Songye Li, Matthias Scheunemann, Shu-fei Lin, Daniel Holden, David Labaree, Jim Ropchan, Rodrigo Teodoro, Winnie Deuther-Conrad, Richard E. Carson, Peter Brust, Yiyun Huang
Renal background correction and measurement of split renal function: The challenge
M. Donald Blaufox
A simple method for determining split renal function from dynamic 99mTc-MAG3 scintigraphic data
Michal J. Wesolowski, Gary R. Conrad, Martin Šámal, Gage Watson, Surajith N. Wanasundara, Paul Babyn, Carl A. Wesolowski
Clinical impact of 99mTc-MAA SPECT/CT-based dosimetry in the radioembolization of liver malignancies with 90Y-loaded microspheres
Etienne Garin, Yan Rolland, Sophie Laffont, Julien Edeline
Radiolabelled choline and FDG PET/CT: two alternatives for the assessment of lymph node metastases in patients with upper urinary tract urothelial carcinoma
Fabio Zattoni, Laura Evangelista, Andrea Guttilla, Filiberto Zattoni
Comments on Kristensen et al.: Clinical value of FDG-PET/CT in suspected paraneoplastic syndromes: a retrospective analysis of 137 patients
Betül Vatankulu, Sabire Yilmaz Aksoy, Sait Sager, Metin Halaç
Reply to: “Comments on Kristensen et al.: Clinical value of FDG-PET/CT in suspected paraneoplastic syndromes: a retrospective analysis of 137 patients”
Stine Bjørn Kristensen, Søren Hess, Henrik Petersen, Poul Flemming Høilund-Carlsen
Nuclear medicine training in the European Union: 2015 update
Alain Prigent, Roland Hustinx, Durval C. Costa
The Young EANM Committee survey
Ozgul Ekmekcioglu, Imene Zerizer, Patrick Pilkington, André H. Dias, Nevena Ristevska, François Jamar